Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects

PURPOSE: Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in clinical development for treatment of gout and asymptomatic hyperuricemia. This study evaluated verinurad pharmacokinetics, pharmacodynamics, and tolerability in healthy Japanese and non-Asian adult male subjects. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Jesse, Gillen, Michael, Liu, Sha, Miner, Jeffrey N, Valdez, Shakti, Shen, Zancong, Lee, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018888/
https://www.ncbi.nlm.nih.gov/pubmed/29950814
http://dx.doi.org/10.2147/DDDT.S152659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018888/
https://www.ncbi.nlm.nih.gov/pubmed/29950814
http://dx.doi.org/10.2147/DDDT.S152659

Ejemplares similares